HIV Prevention in Addiction Care: Insights from Dr. Amy Kennedy
The big takeaways in general from these themes were that providers really hadn't used prep. They never learned about it in their training. Many of the providers actually said that they did find prep to be relevant to their patients, but that honestly they just didn't have the time or it wasn't a priority to them.
How do you tackle HIV prevention among high-risk injection drug users? In this episode of 'Addiction Medicine: Beyond the Abstract', host Shawn McNeil, MD, sits down with Dr. Amy Kennedy, an Acting Assistant Professor of Medicine at the University of Washington and Director of the GMS Addiction Medicine Program at the VA Puget Sound Healthcare System. Dr. Kennedy shares her valuable insights on prescribing HIV preexposure prophylaxis (PrEP) to those who need it most but often fall through the cracks.
She highlights the real-world barriers such as lack of knowledge, time constraints, and shifting priorities that prevent many healthcare providers from utilizing PrEP effectively. Dr. Kennedy emphasizes the importance of harm reduction and personalized patient care, urging providers to see PrEP not just as a medical prescription but as a crucial tool in their harm reduction arsenal. This episode is a must-listen for anyone involved in addiction medicine or interested in the intersection of HIV prevention and substance use treatment.